Back to News
Market Impact: 0.15
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A.
Source: prnewswire.com
Legal & LitigationHealthcare & Biotech
Pomerantz LLP said it is investigating claims on behalf of investors in Cellectis S.A. (NASDAQ: CLLS). The brief announcement provides no details about the claims, alleged conduct, or potential financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.10
Ticker Sentiment
CLLS-0.65
More News
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
- Moderna shares plunge after leak of partial cancer vaccine data
- A lesson from poker tells us not to fold on Meta after its earnings sell-off. Here’s why
- Oura sues rival Ultrahuman again, threatening its U.S. smart ring comeback
- Moderna's stock tumbles after reported leak of data for cancer vaccine
- Personal agents like Meta's Muse could fuel AI’s growth — and challenge Amazon and Apple